T1 and T2 MR fingerprinting measurements of prostate cancer and prostatitis correlate with deep learning-derived estimates of epithelium, lumen, and stromal composition on corresponding whole mount histopathology.
Deep learning
Magnetic resonance imaging
Prostatectomy
Prostatic neoplasms
Prostatitis
Journal
European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
18
03
2020
accepted:
20
08
2020
revised:
10
06
2020
pubmed:
3
9
2020
medline:
15
4
2021
entrez:
3
9
2020
Statut:
ppublish
Résumé
To explore the associations between T1 and T2 magnetic resonance fingerprinting (MRF) measurements and corresponding tissue compartment ratios (TCRs) on whole mount histopathology of prostate cancer (PCa) and prostatitis. A retrospective, IRB-approved, HIPAA-compliant cohort consisting of 14 PCa patients who underwent 3 T multiparametric MRI along with T1 and T2 MRF maps prior to radical prostatectomy was used. Correspondences between whole mount specimens and MRI and MRF were manually established. Prostatitis, PCa, and normal peripheral zone (PZ) regions of interest (ROIs) on pathology were segmented for TCRs of epithelium, lumen, and stroma using two U-net deep learning models. Corresponding ROIs were mapped to T2-weighted MRI (T2w), apparent diffusion coefficient (ADC), and T1 and T2 MRF maps. Their correlations with TCRs were computed using Pearson's correlation coefficient (R). Statistically significant differences in means were assessed using one-way ANOVA. Statistically significant differences (p < 0.01) in means of TCRs and T1 and T2 MRF were observed between PCa, prostatitis, and normal PZ. A negative correlation was observed between T1 and T2 MRF and epithelium (R = - 0.38, - 0.44, p < 0.05) of PCa. T1 MRF was correlated in opposite directions with stroma of PCa and prostatitis (R = 0.35, - 0.44, p < 0.05). T2 MRF was positively correlated with lumen of PCa and prostatitis (R = 0.57, 0.46, p < 0.01). Mean T2 MRF showed significant differences (p < 0.01) between PCa and prostatitis across both transition zone (TZ) and PZ, while mean T1 MRF was significant (p = 0.02) in TZ. Significant associations between MRF (T1 in the TZ and T2 in the PZ) and tissue compartments on corresponding histopathology were observed. • Mean T2 MRF measurements and ADC within cancerous regions of interest dropped with increasing ISUP prognostic groups (IPG). • Mean T1 and T2 MRF measurements were significantly different (p < 0.001) across IPGs, prostatitis, and normal peripheral zone (NPZ). • T2 MRF showed stronger correlations in the peripheral zone, while T1 MRF showed stronger correlations in the transition zone with histopathology for prostate cancer.
Identifiants
pubmed: 32876839
doi: 10.1007/s00330-020-07214-9
pii: 10.1007/s00330-020-07214-9
pmc: PMC7882016
mid: NIHMS1625989
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1336-1346Subventions
Organisme : NCI NIH HHS
ID : 1U24CA199374-01, R01CA202752-01A1, R01CA208236-01A1, R01 CA216579-01A1, R01 CA220581-01A1, 1U01 CA239055-01
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA216579
Pays : United States
Organisme : NCI NIH HHS
ID : 1R01CA208236-01A1
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA199374
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA239055
Pays : United States
Organisme : DOD Prostate Cancer Research Program
ID : Idea Development Award (W81XWH-15-1-0558)
Organisme : U.S. Department of Veterans Affairs
ID : VA Merit Review Award IBX004121A
Organisme : NCI NIH HHS
ID : R01 CA220581
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA202752
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA208236
Pays : United States
Organisme : NCRR NIH HHS
ID : C06 RR012463
Pays : United States
Organisme : DOD Prostate Cancer Research Program
ID : Idea Development Award W81XWH-18-1-0524
Organisme : NCI NIH HHS
ID : U01 CA248226
Pays : United States
Organisme : U.S. Department of Defense
ID : Lung Cancer Investigator-Initiated Translational Research Award (W81XWH-18-1-0440)
Organisme : BLRD VA
ID : I01 BX004121
Pays : United States
Commentaires et corrections
Type : ErratumIn
Références
Radiographics. 2016 Jan-Feb;36(1):162-75
pubmed: 26587887
Urology. 2015 Jan;85(1):147-53
pubmed: 25440986
J Magn Reson Imaging. 2017 Jul;46(1):184-193
pubmed: 27990722
BJU Int. 2001 Jun;87(9):797-805
pubmed: 11412216
Magn Reson Med. 2012 Apr;67(4):1138-45
pubmed: 22294500
Nature. 2013 Mar 14;495(7440):187-92
pubmed: 23486058
Eur Urol Oncol. 2020 Aug;3(4):489-497
pubmed: 31412009
J Urol. 1979 Jun;121(6):755-60
pubmed: 88527
J Urol. 2011 Nov;186(5):1818-24
pubmed: 21944089
Magn Reson Med. 1999 Dec;42(6):1072-81
pubmed: 10571928
Diagn Interv Imaging. 2015 Apr;96(4):365-72
pubmed: 25547670
Diagn Interv Radiol. 2015 Sep-Oct;21(5):382-4
pubmed: 26200484
AJR Am J Roentgenol. 2014 Jan;202(1):109-20
pubmed: 24370135
Radiology. 2019 Sep;292(3):685-694
pubmed: 31335285
AJR Am J Roentgenol. 1987 Oct;149(4):831-7
pubmed: 3307357
Radiology. 2015 Dec;277(3):751-62
pubmed: 26110669
Sci Rep. 2017 Aug 18;7(1):8717
pubmed: 28821786
Invest Radiol. 2009 Sep;44(9):572-6
pubmed: 19692841
J Magn Reson Imaging. 2012 Jul;36(1):213-24
pubmed: 22337003
Invest Radiol. 2019 Aug;54(8):485-493
pubmed: 30985480
PLoS One. 2018 Aug 31;13(8):e0200730
pubmed: 30169514
IEEE Trans Med Imaging. 2010 Jan;29(1):196-205
pubmed: 19923044
Radiology. 2018 Jun;287(3):864-873
pubmed: 29393821
Radiology. 2017 Jun;283(3):729-738
pubmed: 28187264
Br J Radiol. 2014 May;87(1037):20130659
pubmed: 24646125
BJU Int. 2016 Oct;118(4):492-3
pubmed: 27625328
Radiology. 2010 May;255(2):485-94
pubmed: 20413761
Quant Imaging Med Surg. 2013 Aug;3(4):210-6
pubmed: 24040617
Radiology. 2008 Dec;249(3):900-8
pubmed: 19011187
Radiology. 2017 Oct;285(1):147-156
pubmed: 28582632
Radiology. 2013 Apr;267(1):164-72
pubmed: 23329653
Sci Rep. 2018 Oct 8;8(1):14918
pubmed: 30297720